News & Reports
Sign Up for the Policy Watch Newsletter.
Stay updated on the North Bay Leadership Council's latest insights and actions on policies shaping the North Bay community.

MarinHealth Surgery Center Sews Up New Deal
In a surprising reunion, MarinHealth and UCSF Health have teamed up with local physicians to co-own Marin Specialty Surgery Center, marking a significant shift in outpatient surgery services that promises to expand capacity and improve patient care in Marin County—just after years of separation and pandemic challenges.

Dominican University Opens $8M Student Services Building
Dominican University of California has unveiled its $8 million Center for the Dominican Experience, transforming a 1960s library into a cutting-edge student services hub designed to foster community engagement, inclusivity, and a more holistic college experience—an exciting step forward for students and faculty alike.

Kaiser Permanente Healthy Environment, Healthy People
Kaiser Permanente is leading the charge in sustainable healthcare, from achieving carbon-neutral status to building net-zero energy facilities, all while addressing the growing health risks posed by climate change—an urgent mission that could reshape the future of patient care.

Ultragenyx Announces Positive Interim Phase 1/2 Data in Patients with Angelman Syndrome After Treatment with GTX-102
Ultragenyx reveals promising interim Phase 1/2 data showing rapid, multi-domain improvements in patients with Angelman syndrome treated with GTX-102, offering new hope for a disease that currently lacks any approved treatment—find out more about these groundbreaking results and what’s next in their development.